Schuhr Christoph A, Eisenreich Wolfgang, Goese Markus, Stohler Peter, Weber Wolfgang, Kupfer Ernst, Bacher Adelbert
Lehrstuhl für Organische Chemie und Biochemie, Technische Universität München, Lichtenbergstr. 4, D-85747 Garching, Federal Republic of Germany.
J Org Chem. 2002 Apr 5;67(7):2257-62. doi: 10.1021/jo016285v.
Three putative intermediates in the biosynthesis of the lipase inhibitor lipstatin were synthesized in stable isotope-labeled form and were added to fermentation cultures of Streptomyces toxytricini. Biosynthetic lipstatin was isolated and analyzed by NMR spectroscopy. [3,10,11,12-(2)H]-(3S,5Z,8Z)-3-hydroxytetradeca-5,8-dienoic acid (9) was shown to serve as a direct biosynthetic precursor of lipstatin. [7,8-(2)H(2)]Hexylmalonate (11) was also incorporated into lipstatin, albeit at a relatively low rate. The leucine moiety of [(13)C-formyl,(15)N]-N-formylleucine (10) was diverted to lipstatin under loss of the (13)C-labeled formyl residue.
以稳定同位素标记形式合成了脂肪酶抑制剂脂抑素生物合成过程中的三种假定中间体,并将其添加到产毒链霉菌的发酵培养物中。分离出生物合成的脂抑素并通过核磁共振光谱进行分析。结果表明,[3,10,11,12-(2)H]-(3S,5Z,8Z)-3-羟基十四碳-5,8-二烯酸(9)是脂抑素的直接生物合成前体。[7,8-(2)H(2)]己基丙二酸(11)也被整合到脂抑素中,尽管掺入率相对较低。[(13)C-甲酰基,(15)N]-N-甲酰基亮氨酸(10)的亮氨酸部分在(13)C标记的甲酰基残基丢失的情况下被转移到脂抑素中。